You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
科兴:接种第三针灭活疫苗 抗体可迅速提升十倍
阿思达克 06-07 07:51
据《央视新闻》报道,科兴控股生物技术有限公司董事长尹卫东在接受《新闻1+1》采访时表示,现时中国的灭活疫苗,两针完成免疫以後,在体内已经建立起免疫记忆。最近已经完成了二期临床研究,就是打完两针剂次的志愿者,在隔三个月六个月之後接种第三针,抗体可以迅速地在一周内跳到十倍,半个月就可以达到二十倍。但要在真实世界的研究过程中观察,两针疫苗持续保护效果有多长。

尹卫东还表示,将会在半年、一年进行详细的研究测试,然後再建议国家应该在什麽时候加强第三针。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account